<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900521-0113</DOCNO><DOCID>900521-0113.</DOCID><HL>   Who's News:   Chemex Says Chief   Steps Down, Unveils   Cost-Cutting Moves</HL><DATE>05/21/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   CHMX WNEWS</CO><LP>   DENVER -- Chemex Pharmaceuticals Inc. said that itspresident and chief operating officer has resigned and thatthe company has decided to terminate one of two researchagreements it has with Yale University and move into smalleroffices in a bid to cut costs.   The pharmaceutical concern said that Edward S. Neissresigned from his executive positions and as a directoreffective May 1 to pursue other interests. A companyspokesman said the decision was Mr. Neiss's choice. Thecompany said that Mr. Neiss's contract with the company wasto expire in July.</LP><TEXT>   Chemex also said late Friday that it has notified Yalethat it will terminate a general research contract on Sept.30, cutting its Yale research costs in half. The companydeclined to disclose the amount of those research costs.   Chemex also said it agreed in principle with its landlordto move into a 5,000 square foot office from a 32,000 squarefoot office space in the same building. It said it expects tomove in a few weeks.   The company, which had a loss of $6.6 million last year,said that it has an agreement for short-term debt financingsecured by certain company assets, but it declined todisclose the amount or provide details of the agreement.</TEXT></DOC>